M
Michael Hughes
Researcher at Royal Hallamshire Hospital
Publications - 615
Citations - 26328
Michael Hughes is an academic researcher from Royal Hallamshire Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 74, co-authored 531 publications receiving 24066 citations. Previous affiliations of Michael Hughes include Royal College of Physicians & St Thomas' Hospital.
Papers
More filters
Journal ArticleDOI
HIV-1 reverse transcriptase codon 215 mutation in plasma RNA: immunologic and virologic responses to zidovudine. The AIDS Clinical Trials Group Study 175 Virology Team.
TL;DR: Genotypic resistance at codon 215 in plasma HIV RNA is associated with the subsequent immunologic and virologic failure of ZDV monotherapy in subjects with 200 to 500 CD4 cells/mm3.
Journal ArticleDOI
Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study.
Ingrid T. Katz,Erin Leister,Deborah Kacanek,Michael Hughes,Arlene Bardeguez,Elizabeth Livingston,Alice Stek,David Shapiro,Ruth Tuomala +8 more
TL;DR: Socially disadvantaged pregnant women with HIV, who are at greater risk for having detectable viral load at delivery, may benefit from interventions to promote early prenatal care, early HAART initiation, and medication adherence.
Journal ArticleDOI
Significant bacteriuria has prognostic significance in primary biliary cirrhosis
TL;DR: In this study, significant bacteriuria defined a specific sub-group of PBC patients with an increased risk of death, particularly those with late stage disease on liver biopsy.
Journal ArticleDOI
NIAID Workshop, Memphis, Tennessee, 25-26 March 1997: Statistical issues for HIV surrogate endpoints: Point/counterpoint
Jeffrey M. Albert,John P. A. Ioannidis,Patricia Reichelderfer,Brian Conway,Robert W. Coombs,Lawrence R. Crane,Ralph Demasi,Dennis O. Dixon,Phillipe Flandre,Michael Hughes,Leslie A. Kalish,Kinley Larntz,Danyu Lin,Ian C. Marschner,Alvaro Muñoz,Jeffrey Murray,James D. Neaton,Carla Pettinelli,Wasima Rida,Jeremy M. G. Taylor,Seth L. Welles +20 more
TL;DR: The NIAID-sponsored workshop on statistical issues for HIV surrogate endpoints as discussed by the authors explored a series of specific questions dealing with the relationship between markers and clinical endpoints, and the choice of endpoints and methods of analysis in clinical studies.
Journal ArticleDOI
Use of total lymphocyte count for informing when to start antiretroviral therapy in HIV-infected children: a meta-analysis of longitudinal data.
David Dunn,Diana M. Gibb,Trinh Duong,A Babiker,IP Aboulker,Marc Bulterys,Mario Cortina-Borja,Clara Gabiano,Laura Galli,C. Giaquinto,Harris,Michael Hughes,Ross E. McKinney,J Moye,Marie-Louise Newell,Savita Pahwa,Paul Palumbo,Christoph Rudin,Mike Sharland,William T. Shearer,Bruce Thompson,Pat A Tookey,Hiv Paediat Prognostic Markers Col +22 more
TL;DR: In this population of children with HIV, total lymphocyte count was a strong predictor of short-term disease progression, being only marginally less predictive than CD4-cell percentage, and when the markers were compared at the threshold values at which mortality risks were about equal, this resulted in an earlier start of antiretroviral therapy.